Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load

Purpose - - The aim of this study was to analyze chromosomal aberrations in terms of frequency and impact on time to progression in patients with smoldering multiple myeloma (SMM) on the background of clinical prognostic factors. - - Patients and Methods - - The chromosomal abnormalities 1q21, 5p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Neben, Kai (VerfasserIn) , Jauch, Anna (VerfasserIn) , Hielscher, Thomas (VerfasserIn) , Hillengaß, Jens (VerfasserIn) , Giesen, Nicola (VerfasserIn) , Seckinger, Anja (VerfasserIn) , Granzow, Martin (VerfasserIn) , Raab, Marc-Steffen (VerfasserIn) , Ho, Anthony Dick (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Hose, Dirk (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: October 21, 2013
In: Journal of clinical oncology
Year: 2013, Jahrgang: 31, Heft: 34, Pages: 4325-4332
ISSN:1527-7755
DOI:10.1200/JCO.2012.48.4923
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/JCO.2012.48.4923
Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/10.1200/JCO.2012.48.4923
Volltext
Verfasserangaben:Kai Neben, Anna Jauch, Thomas Hielscher, Jens Hillengass, Nicola Lehners, Anja Seckinger, Martin Granzow, Marc S. Raab, Anthony D. Ho, Hartmut Goldschmidt, and Dirk Hose

MARC

LEADER 00000caa a2200000 c 4500
001 1780185057
003 DE-627
005 20220820085306.0
007 cr uuu---uuuuu
008 211203s2013 xx |||||o 00| ||eng c
024 7 |a 10.1200/JCO.2012.48.4923  |2 doi 
035 |a (DE-627)1780185057 
035 |a (DE-599)KXP1780185057 
035 |a (OCoLC)1341434595 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Neben, Kai  |d 1969-  |e VerfasserIn  |0 (DE-588)120842181  |0 (DE-627)080920470  |0 (DE-576)292411774  |4 aut 
245 1 0 |a Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load  |c Kai Neben, Anna Jauch, Thomas Hielscher, Jens Hillengass, Nicola Lehners, Anja Seckinger, Martin Granzow, Marc S. Raab, Anthony D. Ho, Hartmut Goldschmidt, and Dirk Hose 
246 3 0 |a one four fourteen seventeen 
264 1 |c October 21, 2013 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.12.2021 
520 |a Purpose - - The aim of this study was to analyze chromosomal aberrations in terms of frequency and impact on time to progression in patients with smoldering multiple myeloma (SMM) on the background of clinical prognostic factors. - - Patients and Methods - - The chromosomal abnormalities 1q21, 5p15/5q35, 9q34, 13q14.3, 15q22, 17p13, t(11;14)(q13;q32), and t(4;14)(p16.3;q32) were assessed in CD138-purified myeloma cells by interphase fluorescent in situ hybridization (iFISH) alongside clinical parameters in a consecutive series of 248 patients with SMM. - - Results - - The high-risk aberrations in active myeloma (ie, del(17p13), t(4;14), and +1q21) present in 6.1%, 8.9%, and 29.8% of patients significantly confer adverse prognosis in SMM with hazard ratios (HRs) of 2.90 (95% CI, 1.56 to 5.40), 2.28 (95% CI, 1.33 to 3.91), and 1.66 (95% CI, 1.08 to 2.54), respectively. Contrary to the conditions in active myeloma, hyperdiploidy, present in 43.3% of patients, is an adverse prognostic factor (HR, 1.67; 95% CI, 1.10 to 2.54). Percentage of malignant bone marrow plasma cells assessed by iFISH and combination of M-protein and plasma cell infiltration as surrogates of tumor load significantly confer adverse prognosis with HRs of 4.37 (95% CI, 2.79 to 6.85) and 4.27 (95% CI, 2.77 to 6.56), respectively. In multivariate analysis, high-risk aberrations, hyperdiploidy, and surrogates of tumor load are independently prognostic. - - Conclusion - - The high-risk chromosomal aberrations del(17p13), t(4;14), and +1q21 are adverse prognostic factors in SMM just as they are in active myeloma, independent of tumor mass. Hyperdiploidy is the first example for an adverse prognostic factor in SMM of opposite predictiveness in active myeloma. Risk association of chromosomal aberrations is not only a priori treatment dependent (predictive) but is also an intrinsic property of myeloma cells (prognostic). 
700 1 |a Jauch, Anna  |d 1959-  |e VerfasserIn  |0 (DE-588)1025525140  |0 (DE-627)722525362  |0 (DE-576)168357496  |4 aut 
700 1 |a Hielscher, Thomas  |e VerfasserIn  |0 (DE-588)1159594791  |0 (DE-627)1022977768  |0 (DE-576)50506068X  |4 aut 
700 1 |a Hillengaß, Jens  |d 1974-  |e VerfasserIn  |0 (DE-588)124918549  |0 (DE-627)368073823  |0 (DE-576)294568298  |4 aut 
700 1 |a Giesen, Nicola  |d 1983-  |e VerfasserIn  |0 (DE-588)141844272  |0 (DE-627)631828524  |0 (DE-576)32643657X  |4 aut 
700 1 |a Seckinger, Anja  |d 1980-  |e VerfasserIn  |0 (DE-588)134177371  |0 (DE-627)562118225  |0 (DE-576)278603734  |4 aut 
700 1 |a Granzow, Martin  |d 1970-  |e VerfasserIn  |0 (DE-588)121585298  |0 (DE-627)705555712  |0 (DE-576)292784929  |4 aut 
700 1 |a Raab, Marc-Steffen  |d 1973-  |e VerfasserIn  |0 (DE-588)124052460  |0 (DE-627)706520998  |0 (DE-576)293998027  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Hose, Dirk  |d 1969-  |e VerfasserIn  |0 (DE-588)139824995  |0 (DE-627)613790308  |0 (DE-576)313431698  |4 aut 
773 0 8 |i Enthalten in  |t Journal of clinical oncology  |d Alexandria, Va. : American Society of Clinical Oncology, 1983  |g 31(2013), 34, Seite 4325-4332  |h Online-Ressource  |w (DE-627)313116962  |w (DE-600)2005181-5  |w (DE-576)090887018  |x 1527-7755  |7 nnas  |a Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load 
773 1 8 |g volume:31  |g year:2013  |g number:34  |g pages:4325-4332  |g extent:9  |a Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load 
856 4 0 |u https://doi.org/10.1200/JCO.2012.48.4923  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://ascopubs.org/doi/10.1200/JCO.2012.48.4923  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211203 
993 |a Article 
994 |a 2013 
998 |g 139824995  |a Hose, Dirk  |m 139824995:Hose, Dirk  |d 910000  |d 910100  |e 910000PH139824995  |e 910100PH139824995  |k 0/910000/  |k 1/910000/910100/  |p 11  |y j 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |d 50000  |e 910000PG102258023X  |e 910100PG102258023X  |e 50000PG102258023X  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 10 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 9 
998 |g 124052460  |a Raab, Marc-Steffen  |m 124052460:Raab, Marc-Steffen  |d 910000  |d 910100  |e 910000PR124052460  |e 910100PR124052460  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 121585298  |a Granzow, Martin  |m 121585298:Granzow, Martin  |d 910000  |d 911500  |e 910000PG121585298  |e 911500PG121585298  |k 0/910000/  |k 1/910000/911500/  |p 7 
998 |g 134177371  |a Seckinger, Anja  |m 134177371:Seckinger, Anja  |d 910000  |d 910100  |e 910000PS134177371  |e 910100PS134177371  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 141844272  |a Giesen, Nicola  |m 141844272:Giesen, Nicola  |d 910000  |d 910100  |e 910000PG141844272  |e 910100PG141844272  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 124918549  |a Hillengaß, Jens  |m 124918549:Hillengaß, Jens  |d 910000  |d 910100  |e 910000PH124918549  |e 910100PH124918549  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1159594791  |a Hielscher, Thomas  |m 1159594791:Hielscher, Thomas  |d 140000  |e 140000PH1159594791  |k 0/140000/  |p 3 
998 |g 1025525140  |a Jauch, Anna  |m 1025525140:Jauch, Anna  |d 910000  |d 911500  |d 50000  |e 910000PJ1025525140  |e 911500PJ1025525140  |e 50000PJ1025525140  |k 0/910000/  |k 1/910000/911500/  |k 0/50000/  |p 2 
998 |g 120842181  |a Neben, Kai  |m 120842181:Neben, Kai  |d 50000  |e 50000PN120842181  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1780185057  |e 4013309718 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"9 S."}],"name":{"displayForm":["Kai Neben, Anna Jauch, Thomas Hielscher, Jens Hillengass, Nicola Lehners, Anja Seckinger, Martin Granzow, Marc S. Raab, Anthony D. Ho, Hartmut Goldschmidt, and Dirk Hose"]},"relHost":[{"corporate":[{"display":"American Society of Clinical Oncology","role":"isb"}],"language":["eng"],"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}],"part":{"extent":"9","volume":"31","issue":"34","text":"31(2013), 34, Seite 4325-4332","pages":"4325-4332","year":"2013"},"title":[{"title":"Journal of clinical oncology","title_sort":"Journal of clinical oncology","subtitle":"JCO : an American Society of Clinical Oncology journal"}],"origin":[{"dateIssuedKey":"1983","publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins","dateIssuedDisp":"1983-","publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]"}],"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"pubHistory":["1.1983 -"],"disp":"Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor loadJournal of clinical oncology","type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"recId":"313116962","id":{"eki":["313116962"],"zdb":["2005181-5"],"issn":["1527-7755"]}}],"recId":"1780185057","id":{"eki":["1780185057"],"doi":["10.1200/JCO.2012.48.4923"]},"title":[{"title":"Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load","title_sort":"Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load"}],"origin":[{"dateIssuedDisp":"October 21, 2013","dateIssuedKey":"2013"}],"note":["Gesehen am 08.12.2021"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"person":[{"family":"Neben","display":"Neben, Kai","given":"Kai","role":"aut"},{"family":"Jauch","display":"Jauch, Anna","role":"aut","given":"Anna"},{"given":"Thomas","role":"aut","display":"Hielscher, Thomas","family":"Hielscher"},{"display":"Hillengaß, Jens","family":"Hillengaß","role":"aut","given":"Jens"},{"display":"Giesen, Nicola","family":"Giesen","given":"Nicola","role":"aut"},{"role":"aut","given":"Anja","family":"Seckinger","display":"Seckinger, Anja"},{"given":"Martin","role":"aut","family":"Granzow","display":"Granzow, Martin"},{"family":"Raab","display":"Raab, Marc-Steffen","role":"aut","given":"Marc-Steffen"},{"display":"Ho, Anthony Dick","family":"Ho","role":"aut","given":"Anthony Dick"},{"display":"Goldschmidt, Hartmut","family":"Goldschmidt","given":"Hartmut","role":"aut"},{"family":"Hose","display":"Hose, Dirk","role":"aut","given":"Dirk"}]} 
SRT |a NEBENKAIJAPROGRESSIO2120